<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5D55E165-233B-426B-B629-5FFC887C1004"><gtr:id>5D55E165-233B-426B-B629-5FFC887C1004</gtr:id><gtr:name>MRC Technology (MRCT)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9A347F29-3131-4B50-A32A-AF352A437A21"><gtr:id>9A347F29-3131-4B50-A32A-AF352A437A21</gtr:id><gtr:name>General Hospital Salzburg</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B01D4CE2-0A2F-46F4-AEBE-2AAF28293D97"><gtr:id>B01D4CE2-0A2F-46F4-AEBE-2AAF28293D97</gtr:id><gtr:name>European Lead Factory</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:department>Clinical Science at South Bristol</gtr:department><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4A348A76-B2D0-4DDD-804A-CE735A6D3798"><gtr:id>4A348A76-B2D0-4DDD-804A-CE735A6D3798</gtr:id><gtr:name>University of Bristol</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line4>Bristol</gtr:line4><gtr:line5>Avon</gtr:line5><gtr:postCode>BS8 1TH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5D55E165-233B-426B-B629-5FFC887C1004"><gtr:id>5D55E165-233B-426B-B629-5FFC887C1004</gtr:id><gtr:name>MRC Technology (MRCT)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9A347F29-3131-4B50-A32A-AF352A437A21"><gtr:id>9A347F29-3131-4B50-A32A-AF352A437A21</gtr:id><gtr:name>General Hospital Salzburg</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B01D4CE2-0A2F-46F4-AEBE-2AAF28293D97"><gtr:id>B01D4CE2-0A2F-46F4-AEBE-2AAF28293D97</gtr:id><gtr:name>European Lead Factory</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/656AE7EB-E856-4F25-A874-9857FE95083C"><gtr:id>656AE7EB-E856-4F25-A874-9857FE95083C</gtr:id><gtr:firstName>David</gtr:firstName><gtr:surname>Wynick</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0300028"><gtr:id>505A0B0D-967C-455B-B80F-FE45FDF4F7BA</gtr:id><gtr:title>The role of galanin in the adaptive response of the peripheral nervous system to injury</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0300028</gtr:grantReference><gtr:abstractText>Galanin is a small protein that is widely expressed in many nerves of the body and in the endocrine glands that make most of our hormones. The reason that galanin is found in these tissues and its function there is largely unknown, though it is known that the levels of galanin in the nerve increase by a least 100 fold after an injury or cut to the nervous system. To find out more about the galanin protein we have used the new techniques of genetic engineering to generate a mouse strain in which galanin has been removed from every cell in the body (a so called galanin knock-out mouse). We have shown that these knock-out mice are unable to feel pain and their ability to grow back nerves in their limbs following injury is severely impaired. Further, we also have evidence that some cells in the nervous system die after injury when galanin is not present. We now wish to further extend these studies by making further genetically engineered mice with more detailed and specific changes in the galanin levels of the limb nerves. That is to selectively increase and decrease galanin levels in nerves of interest leaving the galanin levels in other parts of the body unchanged. It is hoped that these further studies will greatly advance our understanding of the roles played by galanin in these tissues and may have important implications for the development of possible treatments for the painful nerve complications that result from traumatic injury (eg car accidents) and diabetes.</gtr:abstractText><gtr:technicalSummary>One of the most potent changes observed in the dorsal root ganglion (DRG) following injury, is the 120-fold increase in the levels of twenty-nine amino acid neuropeptide galanin. Galanin is synthesised and stored in the cell bodies of sensory neurons and in the inter-neurons of the dorsal horn of the spinal cord. Work undertaken during my MRC Clinician Scientist Fellowship and Career Establishment Grant has demonstrated that targeted disruption of galanin causes the developmental loss of a subset of DRG neurons. The cell loss may well underlie the marked deficits in chronic neuropathic and inflammatory pain behaviour observed in the mutant mice, implying that galanin is a survival factor for a hitherto uncharacterised population of neurons that are critical for the development of injury-related pain. The trophic role played by galanin in the developing DRG appears to be recapitulated in the adult following injury. A marked reduction in the rate of peripheral nerve regeneration is observed in adult mutants, which is parallelled by deficits in neurite outgrowth from mutant DRG cultures. Most recently, our findings demonstrate that (a) adult sensory neurons are dependent upon galanin for neurite extension, mediated by activation of the second galanin receptor subtype, and (b) inducible or constitutive over-expression of galanin in the adult DRG using transgenesis, supports an inhibitory role for galanin in pain processing, both in the intact animal and in neuropathic pain states.

This programme of research will use a combination of genomic and proteomic approaches to test the hypotheses that galanin receptor activation modulates the developmental survival of a subset of sensory neurons, peripheral nerve regeneration, and chronic neuropathic pain behaviour. Specifically, we will:- (a) use the tetracycline-regulated Tet-Off system to rescue the existing galanin knock-out in an inducible and a DRG-specific manner, allowing us to separate and independently study the roles played by galanin during development and in the adult, (b) use an in-vitro assay we will study the mechanisms that underlie the developmental cell loss in the DRG of the galanin mutants, (c) study the signalling cascades that underlie galanin-induced peripheral nerve regeneration and neuritogenesis in the adult and attempt to identify novel galanin-dependent signalling targets that mediate neurite outgrowth, and (d) characterise the pathways and mechanisms that mediate the changes in pain behaviour observed in the adult mutant animals using transcriptional profiling.</gtr:technicalSummary><gtr:fund><gtr:end>2009-07-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2003-08-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>856568</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>General Hospital Salzburg</gtr:collaboratingOrganisation><gtr:country>Austria, Republic of</gtr:country><gtr:description>galanin and inflammation</gtr:description><gtr:id>E8C35708-6805-434B-9D7C-5F4103C852A3</gtr:id><gtr:impact>17999197</gtr:impact><gtr:outcomeId>35B159EC86E-1</gtr:outcomeId><gtr:partnerContribution>jopint studies resulting in various publications</gtr:partnerContribution><gtr:piContribution>collaboratige studies on inflammation using my transgenic mice</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>MRC Technology (MRCT)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRCT Centre for Therapeutics Discovery (CTD)</gtr:department><gtr:description>identification of novel peptidomimetics for GalR2</gtr:description><gtr:id>478898C9-B1F2-4659-AAA3-FADAE9574ED9</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>EirACTdpArz-1</gtr:outcomeId><gtr:partnerContribution>resources to undertake the HTS and subsequent assays</gtr:partnerContribution><gtr:piContribution>I initiated the collaboration and have worked very closely with the MRCT team to initiate and conduct the screen</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>European Lead Factory</gtr:collaboratingOrganisation><gtr:country>European Union (EU)</gtr:country><gtr:description>HTS for GalR2 PAMs</gtr:description><gtr:id>FF59F664-08DB-4549-BF3F-860A809BD0DD</gtr:id><gtr:impact>None</gtr:impact><gtr:outcomeId>5881d727e8d745.71735466-1</gtr:outcomeId><gtr:partnerContribution>they funded the screen</gtr:partnerContribution><gtr:piContribution>HTS screen for GalR2 PAMs</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>talked at a number of schools in Bristol</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>58E8195B-410F-4B4B-ABF9-5AF5A6589581</gtr:id><gtr:impact>various lectures on biology, medicine and neuroscience

lots of interested and enthused children!</gtr:impact><gtr:outcomeId>5FB5F852ED3</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>AAB website</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E9064EFD-0247-4B11-A6A7-E1FD96BC7E3B</gtr:id><gtr:impact>I co-founded and run the ask a biology website. See http://www.askabiologist.org.uk/punbb/index.php

lots of interested and enthused children!</gtr:impact><gtr:outcomeId>A745A1F0E0E</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007,2008,2009,2010,2011</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>942751</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Strategic Translation Award In Seeding Drug Discovery (Drug discovery of novel allosteric modulators of the second galanin receptor subtype (GalR2) for neuropathic pain.)</gtr:description><gtr:end>2012-02-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>97DE38F0-EC3B-4019-8F4D-847B414F1E1F</gtr:id><gtr:outcomeId>AJapEfmnBDe0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>185000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>The role of galanin and its receptors in painful diabetic neuropathy</gtr:description><gtr:end>2015-05-02</gtr:end><gtr:fundingOrg>Diabetes UK</gtr:fundingOrg><gtr:id>779B18C7-5986-46C8-8979-704710AC9218</gtr:id><gtr:outcomeId>HxRjNy9Ek6L</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-05-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs><gtr:productOutput><gtr:description>we are developing small molecule agonists for Galr2 that will be used to treat neuropathic pain.</gtr:description><gtr:id>FD3FBF0A-4E74-4C60-B59D-8A784F1FD5E4</gtr:id><gtr:impact>these are the first galr2 small molecule agonists ever developed. They are allowing us to further validate galr2 for MS and AD. As the drug devlopment progreses they will be taken into man for neuropathic pain and/or MS or AD.</gtr:impact><gtr:outcomeId>8AFF624F6D2</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>galanin/galr2</gtr:title><gtr:type>Therapeutic Intervention - Drug</gtr:type><gtr:yearDevCompleted>2016</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>I cretaed a large numbre of galanin Tg mice which I am busy distributing to other academics worldwide who need them for their research</gtr:description><gtr:id>14ED63DD-1E7C-4DEC-93DF-7DCDC7DCEE9C</gtr:id><gtr:impact>lots of collaborative publications</gtr:impact><gtr:outcomeId>52A6B418A53</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>transgenic mice</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>CC234ECF-F0C6-4F3D-8EC1-9457E8A9BA79</gtr:id><gtr:title>Activation of the galanin receptor 2 in the periphery reverses nerve injury-induced allodynia.</gtr:title><gtr:parentPublicationTitle>Molecular pain</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8779a1576b6dd1d616701d6dea8e4339"><gtr:id>8779a1576b6dd1d616701d6dea8e4339</gtr:id><gtr:otherNames>Hulse RP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1744-8069</gtr:issn><gtr:outcomeId>kyq6TNGwsx4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C89F441C-3D9B-4607-8483-7BD471B32552</gtr:id><gtr:title>Activation of the galanin receptor 2 (GalR2) protects the hippocampus from neuronal damage.</gtr:title><gtr:parentPublicationTitle>Journal of neurochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/01a5bd500504437df9469f5b7ab1e953"><gtr:id>01a5bd500504437df9469f5b7ab1e953</gtr:id><gtr:otherNames>Elliott-Hunt CR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn><gtr:outcomeId>A72DC49E036</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>28A8DE89-BBD2-4E73-B8AF-1190ED999730</gtr:id><gtr:title>Evaluating the role of a galanin enhancer genotype on a range of metabolic, depressive and addictive phenotypes.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e93a89334f9c50550bc48b84c0467cb"><gtr:id>7e93a89334f9c50550bc48b84c0467cb</gtr:id><gtr:otherNames>Richardson TG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1552-4841</gtr:issn><gtr:outcomeId>56ac72830ac068.28333875</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>34653FE9-D568-4604-B36A-4E393333C486</gtr:id><gtr:title>Targeted disruption of the galanin gene attenuates inflammatory responses in murine skin.</gtr:title><gtr:parentPublicationTitle>Journal of molecular neuroscience : MN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dc06f50658d70dd1fc0c96163bfb4d5d"><gtr:id>dc06f50658d70dd1fc0c96163bfb4d5d</gtr:id><gtr:otherNames>Schmidhuber SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0895-8696</gtr:issn><gtr:outcomeId>54D5E40AE10</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FCCB9C1C-7458-47D1-AB75-6B76508EEA86</gtr:id><gtr:title>Novel mRNA isoforms of the sodium channels Na(v)1.2, Na(v)1.3 and Na(v)1.7 encode predicted two-domain, truncated proteins.</gtr:title><gtr:parentPublicationTitle>Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/737290422b9af099cdf4684c1cb6798f"><gtr:id>737290422b9af099cdf4684c1cb6798f</gtr:id><gtr:otherNames>Kerr NC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0306-4522</gtr:issn><gtr:outcomeId>431DC0FA5F8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>87DADCC9-C3F8-4F21-A85B-ADBB3FD66B45</gtr:id><gtr:title>Peripheral galanin receptor 2 as a target for the modulation of pain.</gtr:title><gtr:parentPublicationTitle>Pain research and treatment</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8779a1576b6dd1d616701d6dea8e4339"><gtr:id>8779a1576b6dd1d616701d6dea8e4339</gtr:id><gtr:otherNames>Hulse RP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2090-1542</gtr:issn><gtr:outcomeId>pm_12410_20_22315681</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E107F1E6-1A8B-4B7E-ABF9-1D7AE666DBB5</gtr:id><gtr:title>The sodium channel Nav1.5a is the predominant isoform expressed in adult mouse dorsal root ganglia and exhibits distinct inactivation properties from the full-length Nav1.5 channel.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular neurosciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/737290422b9af099cdf4684c1cb6798f"><gtr:id>737290422b9af099cdf4684c1cb6798f</gtr:id><gtr:otherNames>Kerr NC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1044-7431</gtr:issn><gtr:outcomeId>7B328A0E4F7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F8DA6566-A969-46AB-BADC-E9BF4FC0F986</gtr:id><gtr:title>Galanin-expression and galanin-dependent sensory neurons are not required for itch.</gtr:title><gtr:parentPublicationTitle>Molecular pain</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9e49db911f8b211f3ca370d5b913b26d"><gtr:id>9e49db911f8b211f3ca370d5b913b26d</gtr:id><gtr:otherNames>Holmes FE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1744-8069</gtr:issn><gtr:outcomeId>54044eb3df0b30.77508063</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>653EFD10-6FAF-42B8-9357-3D0F087457A8</gtr:id><gtr:title>Galanin is an autocrine myelin and oligodendrocyte trophic signal induced by leukemia inhibitory factor.</gtr:title><gtr:parentPublicationTitle>Glia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/849661f65f34125e5db77dc9b95c7d66"><gtr:id>849661f65f34125e5db77dc9b95c7d66</gtr:id><gtr:otherNames>Gresle MM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0894-1491</gtr:issn><gtr:outcomeId>56ac724ecd1da1.52088794</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BA9DABD2-CDE8-421B-B3CA-0DDBA736A928</gtr:id><gtr:title>Characterization of an enhancer region of the galanin gene that directs expression to the dorsal root ganglion and confers responsiveness to axotomy.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a7ae74f7180a1b6335d62592557f5800"><gtr:id>a7ae74f7180a1b6335d62592557f5800</gtr:id><gtr:otherNames>Bacon A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>FE6BEF3D78D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D5153751-9C7E-44C6-853B-40DBA18C2A5E</gtr:id><gtr:title>Characterization of a novel neuropathic pain model in mice.</gtr:title><gtr:parentPublicationTitle>Neuroreport</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1b7bb3bc8430debadc688bce57850d03"><gtr:id>1b7bb3bc8430debadc688bce57850d03</gtr:id><gtr:otherNames>Hulse R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0959-4965</gtr:issn><gtr:outcomeId>FB5E7FD1E74</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1814A476-335A-4810-997C-C9CEB6B34C64</gtr:id><gtr:title>Endogenous galanin protects mouse hippocampal neurons against amyloid toxicity in vitro via activation of galanin receptor-2.</gtr:title><gtr:parentPublicationTitle>Journal of Alzheimer's disease : JAD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/01a5bd500504437df9469f5b7ab1e953"><gtr:id>01a5bd500504437df9469f5b7ab1e953</gtr:id><gtr:otherNames>Elliott-Hunt CR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1387-2877</gtr:issn><gtr:outcomeId>JcKEp72Fiu1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E9B4D8CA-E46C-4390-AA52-1FB251EAFEBF</gtr:id><gtr:title>Sudomotor function and sweat gland innervation in galanin knockout mice.</gtr:title><gtr:parentPublicationTitle>Neuropeptides</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c343d7f1be79f60e92f94aa6334256f7"><gtr:id>c343d7f1be79f60e92f94aa6334256f7</gtr:id><gtr:otherNames>Vilches JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0143-4179</gtr:issn><gtr:outcomeId>pm_12410_20_22698811</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>433BF380-2B49-4E18-B397-AEB1FC5EC9BB</gtr:id><gtr:title>Intra-neural administration of fractalkine attenuates neuropathic pain-related behaviour.</gtr:title><gtr:parentPublicationTitle>Journal of neurochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9e49db911f8b211f3ca370d5b913b26d"><gtr:id>9e49db911f8b211f3ca370d5b913b26d</gtr:id><gtr:otherNames>Holmes FE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn><gtr:outcomeId>4E2332B6DDC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2561192F-A1F0-4A4E-9613-8D348353D7E6</gtr:id><gtr:title>GalR1, but not GalR2 or GalR3, levels are regulated by galanin signaling in the locus coeruleus through a cyclic AMP-dependent mechanism.</gtr:title><gtr:parentPublicationTitle>Journal of neurochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7a02fd32250364e023f74dccef64dadd"><gtr:id>7a02fd32250364e023f74dccef64dadd</gtr:id><gtr:otherNames>Hawes JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn><gtr:outcomeId>8AC8449C4E1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4F3366AA-E82F-47EB-8FFE-2CBE77A77CDC</gtr:id><gtr:title>Novel isoforms of the sodium channels Nav1.8 and Nav1.5 are produced by a conserved mechanism in mouse and rat.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/737290422b9af099cdf4684c1cb6798f"><gtr:id>737290422b9af099cdf4684c1cb6798f</gtr:id><gtr:otherNames>Kerr NC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_12410_10_15047701</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>76C49F3B-E738-4A47-B784-E2769EECB3AA</gtr:id><gtr:title>Galanin stimulates neurite outgrowth from sensory neurons by inhibition of Cdc42 and Rho GTPases and activation of cofilin.</gtr:title><gtr:parentPublicationTitle>Journal of neurochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e272bfeea2cbc25fa73d3db2ddeeb5ae"><gtr:id>e272bfeea2cbc25fa73d3db2ddeeb5ae</gtr:id><gtr:otherNames>Hobson SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn><gtr:outcomeId>54044eb43d0153.53028173</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EEEE907A-DCC7-4A31-83EA-0497B9FE1EEF</gtr:id><gtr:title>The generation of knock-in mice expressing fluorescently tagged galanin receptors 1 and 2.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular neurosciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/183c5071f958631cfad60b14adb9026a"><gtr:id>183c5071f958631cfad60b14adb9026a</gtr:id><gtr:otherNames>Kerr N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1044-7431</gtr:issn><gtr:outcomeId>56ac724e797785.26212981</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E866E763-641D-44D3-A033-0927386261D0</gtr:id><gtr:title>A role for galanin in human and experimental inflammatory demyelination.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6541d20fcd82e9a36f2ac6f0e63dff07"><gtr:id>6541d20fcd82e9a36f2ac6f0e63dff07</gtr:id><gtr:otherNames>Wraith DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>CBD249DF5F6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6935D986-9519-428C-9D2B-7B3F085038F6</gtr:id><gtr:title>Mice deficient for galanin receptor 2 have decreased neurite outgrowth from adult sensory neurons and impaired pain-like behaviour.</gtr:title><gtr:parentPublicationTitle>Journal of neurochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e272bfeea2cbc25fa73d3db2ddeeb5ae"><gtr:id>e272bfeea2cbc25fa73d3db2ddeeb5ae</gtr:id><gtr:otherNames>Hobson SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn><gtr:outcomeId>DC7C41CBA4E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5562715C-284E-48BB-9F11-DB27D12D0537</gtr:id><gtr:title>Galanin plays a role in the conditioning lesion effect in sensory neurons.</gtr:title><gtr:parentPublicationTitle>Neuroreport</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6dc2a83d7896c7b3e743365a5b653057"><gtr:id>6dc2a83d7896c7b3e743365a5b653057</gtr:id><gtr:otherNames>Sachs HH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0959-4965</gtr:issn><gtr:outcomeId>5477B875426</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C6228815-D84B-4836-9556-B91FA45DA97F</gtr:id><gtr:title>Differential roles of galanin on mechanical and cooling responses at the primary afferent nociceptor.</gtr:title><gtr:parentPublicationTitle>Molecular pain</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8779a1576b6dd1d616701d6dea8e4339"><gtr:id>8779a1576b6dd1d616701d6dea8e4339</gtr:id><gtr:otherNames>Hulse RP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1744-8069</gtr:issn><gtr:outcomeId>pm_12410_20_22672616</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>551A7952-E842-4E9F-AAFE-E2BEF7046B1C</gtr:id><gtr:title>Galanin protects against behavioral and neurochemical correlates of opiate reward.</gtr:title><gtr:parentPublicationTitle>Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7a02fd32250364e023f74dccef64dadd"><gtr:id>7a02fd32250364e023f74dccef64dadd</gtr:id><gtr:otherNames>Hawes JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0893-133X</gtr:issn><gtr:outcomeId>5A0DB76D42E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2581625E-B8E3-485A-8B99-A74F610C1452</gtr:id><gtr:title>Characterisation of the nociceptive phenotype of suppressible galanin overexpressing transgenic mice.</gtr:title><gtr:parentPublicationTitle>Molecular pain</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b484cd6cacf619be86308ab2809c214"><gtr:id>6b484cd6cacf619be86308ab2809c214</gtr:id><gtr:otherNames>Pope RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1744-8069</gtr:issn><gtr:outcomeId>dWjvzPuLCWF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F9EEE658-DA66-442F-93B0-21C01C3834B6</gtr:id><gtr:title>Targeted disruption of the orphan receptor Gpr151 does not alter pain-related behaviour despite a strong induction in dorsal root ganglion expression in a model of neuropathic pain.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular neurosciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9e49db911f8b211f3ca370d5b913b26d"><gtr:id>9e49db911f8b211f3ca370d5b913b26d</gtr:id><gtr:otherNames>Holmes FE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1044-7431</gtr:issn><gtr:outcomeId>5881d5a98710d0.20825553</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>68AE547C-07D4-4A8F-8694-368FD5AC0B7B</gtr:id><gtr:title>Physiology, signaling, and pharmacology of galanin peptides and receptors: three decades of emerging diversity.</gtr:title><gtr:parentPublicationTitle>Pharmacological reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e7d942b874d301c61a08e896158099a"><gtr:id>0e7d942b874d301c61a08e896158099a</gtr:id><gtr:otherNames>Lang R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0031-6997</gtr:issn><gtr:outcomeId>56ac724ea7fc91.61060100</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2E244F93-0E3E-42A1-8586-3122927831BB</gtr:id><gtr:title>The expression of ELK transcription factors in adult DRG: Novel isoforms, antisense transcripts and upregulation by nerve damage.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular neurosciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/183c5071f958631cfad60b14adb9026a"><gtr:id>183c5071f958631cfad60b14adb9026a</gtr:id><gtr:otherNames>Kerr N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1044-7431</gtr:issn><gtr:outcomeId>QNWpmLrWCzn</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ADEA162F-0296-4171-80B4-0D799DCF8D3B</gtr:id><gtr:title>Use of genetically engineered transgenic mice to investigate the role of galanin in the peripheral nervous system after injury.</gtr:title><gtr:parentPublicationTitle>Neuropeptides</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9e49db911f8b211f3ca370d5b913b26d"><gtr:id>9e49db911f8b211f3ca370d5b913b26d</gtr:id><gtr:otherNames>Holmes FE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0143-4179</gtr:issn><gtr:outcomeId>0873F15C446</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>650EB75C-7646-40DE-84E4-27337312AC38</gtr:id><gtr:title>Galanin acts as a trophic factor to the central and peripheral nervous systems.</gtr:title><gtr:parentPublicationTitle>Cellular and molecular life sciences : CMLS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e272bfeea2cbc25fa73d3db2ddeeb5ae"><gtr:id>e272bfeea2cbc25fa73d3db2ddeeb5ae</gtr:id><gtr:otherNames>Hobson SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1420-682X</gtr:issn><gtr:outcomeId>C17CBEE77C3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C69FF8C0-7A76-49B2-B463-6855FE43DAA5</gtr:id><gtr:title>The role of physical activity and psychological coping strategies in the management of painful diabetic neuropathy--A systematic review of the literature.</gtr:title><gtr:parentPublicationTitle>Physiotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/39805b81c63c9d4885e43efb917b3d25"><gtr:id>39805b81c63c9d4885e43efb917b3d25</gtr:id><gtr:otherNames>Davies B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0031-9406</gtr:issn><gtr:outcomeId>56ac724e4db7a5.83592437</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>080F3C7F-3A63-4C21-B79F-3E1BFC4F590E</gtr:id><gtr:title>Effect of neocortical and hippocampal amyloid deposition upon galaninergic and cholinergic neurites in A?PPswe/PS1?E9 mice.</gtr:title><gtr:parentPublicationTitle>Journal of Alzheimer's disease : JAD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6846a33b17b67194c3454ab8c98f3f04"><gtr:id>6846a33b17b67194c3454ab8c98f3f04</gtr:id><gtr:otherNames>Kelley CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1387-2877</gtr:issn><gtr:outcomeId>LtisrNmgXTo</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>55F663D7-FB9C-4A34-AA21-5A4BCCD70E29</gtr:id><gtr:title>Axotomy-induced miR-21 promotes axon growth in adult dorsal root ganglion neurons.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/02d1a9a49a5aec691248f7a71f02dff4"><gtr:id>02d1a9a49a5aec691248f7a71f02dff4</gtr:id><gtr:otherNames>Strickland IT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>YWu39B16qYR</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E076789-9801-456C-B7A8-3CC22E16556F</gtr:id><gtr:title>Galanin negatively modulates opiate withdrawal via galanin receptor 1.</gtr:title><gtr:parentPublicationTitle>Psychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9e49db911f8b211f3ca370d5b913b26d"><gtr:id>9e49db911f8b211f3ca370d5b913b26d</gtr:id><gtr:otherNames>Holmes FE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0033-3158</gtr:issn><gtr:outcomeId>aTRW3xENbfU</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A7C7C0FA-CA61-4718-B2E4-355AFAE8B5A0</gtr:id><gtr:title>Osteopontin expression and function within the dorsal root ganglion.</gtr:title><gtr:parentPublicationTitle>Neuroreport</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/716c785658b0661166a070d0544ad2fb"><gtr:id>716c785658b0661166a070d0544ad2fb</gtr:id><gtr:otherNames>Marsh BC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0959-4965</gtr:issn><gtr:outcomeId>FFAD291BA0E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>056A5A55-EE6B-4A33-8BEA-3743A5498DB8</gtr:id><gtr:title>Feeding behaviour in galanin knockout mice supports a role of galanin in fat intake and preference.</gtr:title><gtr:parentPublicationTitle>Journal of neuroendocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bce01ff7558604a467e4f7036c1575e4"><gtr:id>bce01ff7558604a467e4f7036c1575e4</gtr:id><gtr:otherNames>Adams AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0953-8194</gtr:issn><gtr:outcomeId>BA301829964</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E89AF796-FC3B-4664-933D-85D61D945312</gtr:id><gtr:title>Intact cutaneous C fibre afferent properties in mechanical and cold neuropathic allodynia.</gtr:title><gtr:parentPublicationTitle>European journal of pain (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1b7bb3bc8430debadc688bce57850d03"><gtr:id>1b7bb3bc8430debadc688bce57850d03</gtr:id><gtr:otherNames>Hulse R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1090-3801</gtr:issn><gtr:outcomeId>F52B36B423E</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0300028</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>